Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Descriptive Analysis of VTE Treatment With Rivaroxaban in Japanese Clinical Practice Using a Claims Database

NCT04923139 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04923139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04923139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Descriptive Analysis of VTE Treatment With Rivaroxaban in Japanese Clinical Practice Using a Claims Database
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
January 24, 2022
Completion date
December 31, 2022
Enrollment
2,627 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

treatment of venous thromboembolism